Life sciences partner Katherine Wang (Shanghai) chaired a medical device regulatory affairs roundtable co-organized with McKinsey & Company in Beijing on April 13. The roundtable brought together 20 senior regulatory affairs (RA) leaders from multinational medical device companies.
Ms. Wang led discussions on the key China Food and Drug Administration regulatory updates affecting medical device operations in China and how the RA function can be better prepared for these changes. The group strategized how to align the Chinese regulatory requirements with global development and how to build industry channels to influence and shape future policies.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.